Groundbreaking neurostimulation technology offers hope and healing for difficult-to-manage pain. Chronic low back pain, a formidable foe causing disability and soaring healthcare costs, now faces a ...
CLEVELAND, March 02, 2021 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., a leader in neurostimulation technology for pain management, announced publication of clinical data evaluating the impact of ...
Please provide your email address to receive an email when new articles are posted on . Results published in Orthopedics showed facet joint osteoarthritis was associated with a higher multifidus ...
Background The optimal components of postoperative exercise programmes following single-level lumbar discectomy have not been identified. Facilitating lumbar multifidus (LM) function after discectomy ...
DUBLIN--(BUSINESS WIRE)--Mainstay Medical today announced that the United States Centers for Disease Control and Prevention (CDC) has designated an International Classification of Diseases, Tenth ...
Background The high prevalence of non-specific low back pain and its correlation with the findings in the lumbar multifidus muscles (electromyography activity, morphology and thickness) and good ...
Mainstay Medical Holdings plc has won U.S. FDA approval for its Reactiv8 implantable neurostimulation device. The company is eyeing a commercial launch of the system in early 2021. The FDA approved ...
Low back pain is one of the most frequently reported complaints in the military. We all joke about it, especially as we get older. We groan when we stand up. We exaggerate the effort it takes to put ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback